Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16401-16450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03794011
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study
PHASE1
Active, not recruiting
38 participants
Started: Dec 18, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
2 locations
NCT03707938
Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
35 participants
Started: Dec 18, 2018 · Completed: Jan 28, 2026
7 conditions
2 sponsors
1 location
NCT03737214
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
PHASE3
Active, not recruiting
107 participants
Started: Dec 18, 2018 · Completed: Nov 30, 2029
1 condition
1 sponsor
42 locations
NCT03740165
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
PHASE3
Active, not recruiting
1,367 participants
Started: Dec 18, 2018 · Completed: May 29, 2026
3 conditions
3 sponsors
227 locations
NCT04302311
Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist
NA
Active, not recruiting
73 participants
Started: Dec 18, 2018 · Completed: Mar 31, 2024
4 conditions
1 sponsor
1 location
NCT07047131
Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants
PHASE3
Active, not recruiting
50 participants
Started: Dec 18, 2018 · Completed: Dec 20, 2030
4 conditions
1 sponsor
1 location
NCT03642626
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
PHASE2
Active, not recruiting
144 participants
Started: Dec 18, 2018 · Completed: Jun 1, 2028
2 conditions
1 sponsor
1 location
NCT03804502
Pilot Study of TearCare System - Long-Term Extension
NA
Active, not recruiting
8 participants
Started: Dec 17, 2018 · Completed: Jul 31, 2019
1 condition
1 sponsor
1 location
NCT02932956
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
PHASE1
Active, not recruiting
10 participants
Started: Dec 17, 2018 · Completed: Feb 28, 2037
1 condition
6 sponsors
1 location
NCT03765918
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
PHASE3
Active, not recruiting
714 participants
Started: Dec 17, 2018 · Completed: Sep 10, 2026
1 condition
1 sponsor
192 locations
NCT03750331
Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
NA
Active, not recruiting
738 participants
Started: Dec 17, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT03778554
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
PHASE4
Active, not recruiting
2,760 participants
Started: Dec 17, 2018 · Completed: Dec 10, 2035
3 conditions
25 sponsors
1 location
NCT03533673
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
PHASE1/PHASE2
Active, not recruiting
7 participants
Started: Dec 17, 2018 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03819985
Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk
PHASE2
Active, not recruiting
122 participants
Started: Dec 17, 2018 · Completed: Aug 31, 2027
8 conditions
2 sponsors
1 location
NCT04259125
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
N/A
Active, not recruiting
87 participants
Started: Dec 15, 2018 · Completed: Dec 1, 2025
4 conditions
5 sponsors
4 locations
NCT03600233
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
PHASE2
Active, not recruiting
34 participants
Started: Dec 15, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
8 locations
NCT03697850
Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy
PHASE2
Active, not recruiting
79 participants
Started: Dec 14, 2018 · Completed: Feb 15, 2029
1 condition
2 sponsors
12 locations
NCT03710603
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
PHASE3
Active, not recruiting
709 participants
Started: Dec 14, 2018 · Completed: Nov 30, 2029
1 condition
2 sponsors
13 locations
NCT03614260
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NA
Active, not recruiting
225 participants
Started: Dec 14, 2018 · Completed: Jul 31, 2027
3 conditions
1 sponsor
47 locations
NCT03774836
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
PHASE3
Active, not recruiting
360 participants
Started: Dec 14, 2018 · Completed: Jun 30, 2019
1 condition
1 sponsor
3 locations
NCT03673124
Ribociclib and Letrozole Treatment in Ovarian Cancer
PHASE2
Active, not recruiting
51 participants
Started: Dec 14, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
27 locations
NCT03773367
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
PHASE2
Active, not recruiting
60 participants
Started: Dec 14, 2018 · Completed: Nov 30, 2026
1 condition
1 sponsor
4 locations
NCT03572764
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
PHASE1
Active, not recruiting
20 participants
Started: Dec 14, 2018 · Completed: Mar 25, 2027
1 condition
2 sponsors
3 locations
NCT03789604
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
479 participants
Started: Dec 13, 2018 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03769155
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
PHASE1
Active, not recruiting
41 participants
Started: Dec 13, 2018 · Completed: Dec 15, 2032
3 conditions
5 sponsors
1 location
NCT03601078
An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma
PHASE2
Active, not recruiting
248 participants
Started: Dec 13, 2018 · Completed: Oct 15, 2025
1 condition
1 sponsor
25 locations
NCT03771508
Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
N/A
Active, not recruiting
8,000 participants
Started: Dec 13, 2018 · Completed: Sep 30, 2025
6 conditions
1 sponsor
30 locations
NCT03783507
Foods Within a Meal and Food Liking Study
NA
Active, not recruiting
62 participants
Started: Dec 13, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03483038
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
PHASE2
Active, not recruiting
45 participants
Started: Dec 13, 2018 · Completed: Feb 28, 2026
1 condition
2 sponsors
4 locations
NCT05142800
Screening For BCRL In Targeted Therapy For Breast Cancer
N/A
Active, not recruiting
166 participants
Started: Dec 13, 2018 · Completed: Sep 30, 2026
11 conditions
2 sponsors
1 location
NCT03755804
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
PHASE2
Active, not recruiting
232 participants
Started: Dec 12, 2018 · Completed: Jul 1, 2028
1 condition
3 sponsors
8 locations
NCT03652545
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
PHASE1
Active, not recruiting
33 participants
Started: Dec 12, 2018 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT03984318
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NA
Active, not recruiting
1,240 participants
Started: Dec 12, 2018 · Completed: Dec 11, 2028
1 condition
1 sponsor
5 locations
NCT03694249
Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
PHASE2
Active, not recruiting
30 participants
Started: Dec 12, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT03742895
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
PHASE2
Active, not recruiting
390 participants
Started: Dec 12, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
130 locations
NCT03762850
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
PHASE3
Active, not recruiting
406 participants
Started: Dec 11, 2018 · Completed: Jul 31, 2026
1 condition
1 sponsor
162 locations
NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
PHASE2
Active, not recruiting
40 participants
Started: Dec 11, 2018 · Completed: Dec 31, 2030
13 conditions
1 sponsor
35 locations
NCT03585114
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
PHASE2
Active, not recruiting
11 participants
Started: Dec 11, 2018 · Completed: Dec 31, 2022
1 condition
1 sponsor
1 location
NCT03639025
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
N/A
Active, not recruiting
458 participants
Started: Dec 10, 2018 · Completed: Nov 30, 2029
1 condition
1 sponsor
18 locations
NCT02997878
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Dec 7, 2018 · Completed: Oct 1, 2025
2 conditions
2 sponsors
1 location
NCT03701334
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
PHASE3
Active, not recruiting
5,101 participants
Started: Dec 7, 2018 · Completed: May 29, 2026
1 condition
2 sponsors
387 locations
NCT03579316
Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2
Active, not recruiting
96 participants
Started: Dec 7, 2018 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT03800134
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
PHASE3
Active, not recruiting
825 participants
Started: Dec 6, 2018 · Completed: Sep 11, 2028
1 condition
1 sponsor
231 locations
NCT03766126
Lentivirally Redirected CD123 Autologous T Cells in AML
PHASE1
Active, not recruiting
22 participants
Started: Dec 6, 2018 · Completed: Dec 3, 2033
3 conditions
1 sponsor
1 location
NCT03549715
NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma
PHASE1/PHASE2
Active, not recruiting
121 participants
Started: Dec 6, 2018 · Completed: Sep 30, 2025
1 condition
1 sponsor
15 locations
NCT03670056
Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
PHASE2
Active, not recruiting
25 participants
Started: Dec 6, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03562637
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
PHASE3
Active, not recruiting
575 participants
Started: Dec 5, 2018 · Completed: Dec 30, 2027
1 condition
1 sponsor
128 locations
NCT06209983
The Effect of Enhanced Recovery After Surgery (ERAS) in Gastric Cancer Surgery
NA
Active, not recruiting
38 participants
Started: Dec 5, 2018 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03806426
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
PHASE3
Active, not recruiting
204 participants
Started: Dec 5, 2018 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT03777813
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
PHASE2
Active, not recruiting
112 participants
Started: Dec 5, 2018 · Completed: Sep 1, 2025
2 conditions
1 sponsor
7 locations
Previous
1
More pages
326
327
328
329
330
331
332
More pages
431
Next